drugset / Trial / NCT04311658

Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion

NCT04311658

Phase 3 Unknown 88 enrolled Cairo University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

the aim of the study is to evaluate the safety and efficacy of isosorbide mononitrate vaginal administration in reducing pain during LNG-IUD insertion in adolescents and young women

Timeline

Start
2020-03-30
Primary completion
2020-06-25
Completion
2020-07-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 40 mg Other

Indications

No indication recorded.